Skip to main content
. 2017 Aug 28;9(8):1337–1348. doi: 10.1080/19420862.2017.1366395

Table 3.

Light chain peptides identified with possible serine to asparagine substitution in RAZUMAB batches. Variant peptides of RAZUMAB light chain are shown along with the possible position of the serine to asparagine (Ser → Asn) substitution. The LC peptide number after LysC cleavage (#), the corresponding amino acid range, and the peptide sequence are shown for each entry. The possible positions of the Ser → Asn substitution are indicated in red italic and in red bold underlined when position is confirmed. Additional peptide properties are included such as retention time (RT), mass-to-charge ratio (m/z), charge, observed mass (Da), and mass delta calculated as the difference between the observed and expected precursor masses divided by the expected precursor mass multiplied by 106 (ppm). The percentage of Ser → Asn misincorporation is determined for each variant peptide as the volume of the variant peptide cluster divided by the sum of the volumes of the variant and its corresponding native peptide m/z. Results for 2 independent experiments are shown in which batch 1 was analyzed altogether with batch 2 or batch 5. Batches 2 and 5 were analyzed only in separate experiments. Values for batch 1 are reported for both experiments to assess inter-experiment reproducibility. Coefficient of variation (CV) is calculated for each ion based on the estimates obtained for batch 1 in these 2 independent experiments. *potential overestimation due to the presence of substantial sodium adduct. ‡ Signature ions for partial Ser → Asn substitution were detected for each of the 4 serine residues of peptide L-L9, indicating that the variant ion at 1081.49 m/z is a mixture of several isobaric peptides with partial misintegration of Asn for Ser at all 4 sites as observed in the chimeric MS/MS spectrum.

                  Misincorporation (%)
                  Experiment 1
Experiment 2
 
#
Range
Sequence
Ser→Asn [position]
RT [min]
m/z [Th]
Charge
Mass [Da]
Mass Delta [ppm]
batch 1
batch 2
batch 1
batch 5
CV batch 1 (%)
L-L1 1–39 DIQLTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQK 30 80.1 1463.38 3 4387.12 3.0 1.5 2.0 1.2 1.7 15
L-L1 1–39 DIQLTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQK 14 81.1 1463.37 3 4387.09 −2.9 1.5* 2.1* 2.4* 3.2* 33
L-L4 46–103 VLYIFTSSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSTVPWTFGQGTK 76 or 77 93.5 1608.51 4 6430.03 −3.5 5.0 6.6 5.4 7.2 6
L-L6 108–126 RTVAAPSVFIFPPSDEQLK 114 70.8 1065.08 2 2128.14 3.3 0.4 0.5 0.4 0.5 10
L-L7 127–145 SGTASVVCLLNNFYPREAK 131 78.3 1077.05 2 2152.08 1.2 0.5 0.7 0.6 0.7 12
L-L9 150–169 VDNALQSGNSQESVTEQDSK 156, 159, 162, and 168‡ 30.8 1081.49 2 2160.96 −6.8 2.2 3.1 1.9 1.9 11
L-L10 170–183 DSTYSLSSTLTLSK 176 50.9 765.39 2 1528.76 0.7 0.6 0.7 0.5 0.7 7
L-L10 170–183 DSTYSLSSTLTLSK 177 52.8 765.39 2 1528.76 −1.1 2.9 4.0 2.6 3.5 6
L-L13 191–207 VYACEVTHQGLSSPVTK 202 or 203 42.6 951.97 2 1901.93 −0.7 0.7 0.9 0.6 0.7 18